Who owns Bioxcel Therapeutics Inc?
- Ticker: BTAI
- CUSIP Number: 09075p105
Tip: Access positions for across all investors
Analyze quarterly positions in Bioxcel Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Bioxcel Therapeutics stock
Who bought or sold Bioxcel Therapeutics Inc this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
FMR | 2.7M | $6.8M | -38% | Sep 2023 |
|
BlackRock | 1.3M | $3.3M | -7% | Sep 2023 |
|
Vanguard Group | 1.1M | $3.2M | -11% | Dec 2023 |
|
Ameriprise Financial | 668k | $1.7M | 91% | Sep 2023 |
|
Susquehanna International | 464k | $1.2M | -20% | Sep 2023 |
|
Geode Capital Management | 423k | $1.1M | 5% | Sep 2023 |
|
State Street Corporation | 410k | $1.0M | -80% | Sep 2023 |
|
Beacon Pointe Advisors | 302k | $890k | 0% | Dec 2023 |
|
Northern Trust | 226k | $571k | -8% | Sep 2023 |
|
Morgan Stanley | 203k | $514k | 119% | Sep 2023 |
|
Adage Capital Partners GP | 200k | $506k | -90% | Sep 2023 |
|
Charles Schwab Investment Management | 188k | $553k | 37% | Dec 2023 |
|
Citadel Advisors | 152k | $448k | -2% | Dec 2023 |
|
Bank of New York Mellon | 127k | $373k | -1% | Dec 2023 |
|
Arete Wealth Advisors | 109k | $322k | 100% | Dec 2023 |
|
Bank of America Corporation | 104k | $308k | 2% | Dec 2023 |
|
Bank Of Montreal | 89k | $283k | 4% | Dec 2023 |
|
Millennium Management | 88k | $260k | -40% | Dec 2023 |
|
Wells Fargo & Company | 78k | $230k | 4% | Dec 2023 |
|
Virtu Financial | 60k | $176k | 100% | Dec 2023 |
|
Squarepoint Ops | 57k | $168k | 100% | Dec 2023 |
|
Tocqueville Asset Management | 50k | $148k | 27% | Dec 2023 |
|
UBS Group | 48k | $143k | -39% | Dec 2023 |
|
D. E. Shaw & Co | 42k | $125k | 100% | Dec 2023 |
|
Group One Trading | 39k | $98k | 100% | Sep 2023 |
|
Cambridge Investment Research Advisors | 38k | $112k | 100% | Dec 2023 |
|
Wellington Management Company | 37k | $109k | 0% | Dec 2023 |
|
Hennion & Walsh Asset Management | 37k | $108k | 8% | Dec 2023 |
|
Davenport & Co | 35k | $104k | -42% | Dec 2023 |
|
XTX Topco | 34k | $85k | 104% | Sep 2023 |
|
Jane Street | 31k | $92k | -78% | Dec 2023 |
|
Alliancebernstein | 30k | $89k | -16% | Dec 2023 |
|
Rhumbline Advisers | 29k | $86k | 6% | Dec 2023 |
|
Barclays | 28k | $82k | 264% | Dec 2023 |
|
Y-Intercept | 28k | $70k | 100% | Sep 2023 |
|
Bnp Paribas Arbitrage, Snc | 23k | $69k | -69% | Dec 2023 |
|
California State Teachers Retirement System | 23k | $57k | -7% | Sep 2023 |
|
Engineers Gate Manager | 22k | $56k | 100% | Sep 2023 |
|
Driehaus Capital Management | 22k | $56k | 0% | Sep 2023 |
|
Creative Planning | 20k | $60k | -5% | Dec 2023 |
|
Thrivent Financial for Lutherans | 20k | $50k | 100% | Sep 2023 |
|
Goldman Sachs Group | 19k | $57k | -86% | Dec 2023 |
|
Raymond James & Associates | 19k | $56k | 13% | Dec 2023 |
|
SeaCrest Wealth Management | 18k | $51k | 10% | Dec 2023 |
|
Us Bancorp | 18k | $53k | 0% | Dec 2023 |
|
Capital Investment Advisory Services | 18k | $53k | -1% | Dec 2023 |
|
Deutsche Bank Aktiengesellschaft | 18k | $52k | 612% | Dec 2023 |
|
Nuveen Asset Management | 15k | $38k | 0% | Sep 2023 |
|
Crossmark Global Holdings | 13k | $43k | 1% | Sep 2023 |
|
Jpmorgan Chase & Co | 13k | $38k | -1% | Dec 2023 |
|
Branch Banking & Trust Company | 11k | $32k | 100% | Dec 2023 |
|
Apollon Wealth Management | 11k | $31k | 100% | Dec 2023 |
|
American International | 10k | $30k | 0% | Dec 2023 |
|
Zurcher Kantonalbank | 7.9k | $23k | -31% | Dec 2023 |
|
Qube Research & Technologies | 7.4k | $19k | 100% | Sep 2023 |
|
Royal Bank of Canada | 6.7k | $18k | 118% | Dec 2023 |
|
AllSquare Wealth Management | 4.5k | $13k | 0% | Dec 2023 |
|
Tower Research Capital | 4.1k | $11k | -28% | Sep 2023 |
|
Cutler | 3.1k | $9.0k | -70% | Dec 2023 |
|
Legal & General Group | 3.0k | $8.9k | -77% | Dec 2023 |
|
Citigroup | 2.9k | $8.4k | -88% | Dec 2023 |
|
Amalgamated Bank | 2.8k | $8.0k | -7% | Dec 2023 |
|
Washington Trust Advisors | 2.6k | $7.6k | 106% | Dec 2023 |
|
Quantbot Technologies | 2.1k | $5.3k | 100% | Sep 2023 |
|
National Bank Of Canada /fi/ | 1.9k | $5.5k | 60% | Dec 2023 |
|
Northwestern Mutual Wealth Management Company | 1.7k | $4.4k | 0% | Sep 2023 |
|
Summit Investment Advisors | 1.4k | $4.0k | 0% | Dec 2023 |
|
Armstrong Advisory Group | 1.0k | $3.0k | 0% | Dec 2023 |
|
Pnc Financial Services | 937.00 | $2.8k | 100% | Dec 2023 |
|
Great-West Life Assurance Company | 736.00 | $2.0k | 0% | Sep 2023 |
|
Toth Financial Advisory Corporation | 500.00 | $1.5k | 0% | Dec 2023 |
|
Goss Wealth Management | 500.00 | $1.3k | -75% | Sep 2023 |
|
Advisor Group Holdings | 430.00 | $1.3k | 43% | Dec 2023 |
|
New York State Common Retirement Fund | 273.00 | $999.999000 | -10% | Dec 2023 |
|
Russell Investments | 88.00 | $259.996000 | 100% | Dec 2023 |
|
Who sold out of Bioxcel Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Two Sigma Investments | Sep 2023 | 433k | $1.1M |
Rafferty Asset Management | Jun 2023 | 198k | $1.3M |
Ghost Tree Capital | Jun 2023 | 130k | $866k |
Two Sigma Advisers | Sep 2023 | 74k | $187k |
Hrt Financial | Sep 2023 | 72k | $182k |
HAP Trading | Jun 2023 | 63k | $2.2k |
Knoll Capital Management | Sep 2023 | 60k | $152k |
Swiss National Bank | Sep 2023 | 44k | $112k |
ProFund Advisors | Jun 2023 | 36k | $236k |
Marshall Wace | Sep 2023 | 28k | $71k |
Credit Suisse | Sep 2023 | 22k | $55k |
Balyasny Asset Management | Sep 2023 | 21k | $53k |
UBS O'Connor | Jun 2023 | 16k | $400.000000 |
Point72 Middle East FZE | Sep 2023 | 16k | $40k |
Simplex Trading | Sep 2023 | 8.1k | $20k |
Virtus ETF Advisers | Sep 2023 | 4.6k | $12k |
Allspring Global Investments Holdings | Sep 2023 | 4.4k | $11k |
Point72 Asset Management | Sep 2023 | 2.7k | $6.8k |
Fifth Third Bancorp | Sep 2023 | 1.0k | $2.5k |
Legacy Financial Group | Sep 2023 | 210.00 | $531k |
CWM | Sep 2023 | 138.00 | $0 |
NISA Investment Advisors | Sep 2023 | 97.00 | $245.002600 |